Antipsychotic efficacy of fluperlapine. An open multicenter trial

Neuropsychobiology. 1984;11(2):116-20. doi: 10.1159/000118064.

Abstract

In an open multicenter trial 46 schizophrenic patients were treated with fluperlapine for 20 days. A mean daily dosage of 300-400 mg appeared to be an effective antipsychotic treatment in most cases. The marked antipsychotic effect was accompanied by a good improvement of depressive symptoms. Extrapyramidal side effects were extremely rare.

Publication types

  • Clinical Trial

MeSH terms

  • Adult
  • Antipsychotic Agents / adverse effects
  • Antipsychotic Agents / therapeutic use*
  • Clinical Trials as Topic
  • Dibenzazepines / therapeutic use*
  • Dose-Response Relationship, Drug
  • Electroencephalography
  • Female
  • Humans
  • Male
  • Psychiatric Status Rating Scales
  • Psychotic Disorders / drug therapy*
  • Psychotic Disorders / psychology
  • Schizophrenia / drug therapy*
  • Schizophrenic Psychology

Substances

  • Antipsychotic Agents
  • Dibenzazepines
  • fluperlapine